Piramal Pharma Ltd
NSE:PPLPHARMA
Intrinsic Value
The intrinsic value of one PPLPHARMA stock under the Base Case scenario is 142.76 INR. Compared to the current market price of 226.72 INR, Piramal Pharma Ltd is Overvalued by 37%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Piramal Pharma Ltd
Fundamental Analysis

Revenue & Expenses Breakdown
Piramal Pharma Ltd
Balance Sheet Decomposition
Piramal Pharma Ltd
Current Assets | 53.8B |
Cash & Short-Term Investments | 4.5B |
Receivables | 18.3B |
Other Current Assets | 31B |
Non-Current Assets | 98.6B |
Long-Term Investments | 2.5B |
PP&E | 49.2B |
Intangibles | 41.8B |
Other Non-Current Assets | 5.1B |
Free Cash Flow Analysis
Piramal Pharma Ltd
INR | |
Free Cash Flow | INR |
Earnings Waterfall
Piramal Pharma Ltd
Revenue
|
89.5B
INR
|
Cost of Revenue
|
-32.9B
INR
|
Gross Profit
|
56.6B
INR
|
Operating Expenses
|
-45.4B
INR
|
Operating Income
|
11.2B
INR
|
Other Expenses
|
-10.8B
INR
|
Net Income
|
389m
INR
|
PPLPHARMA Profitability Score
Profitability Due Diligence
Piramal Pharma Ltd's profitability score is 51/100. The higher the profitability score, the more profitable the company is.
Score
Piramal Pharma Ltd's profitability score is 51/100. The higher the profitability score, the more profitable the company is.
PPLPHARMA Solvency Score
Solvency Due Diligence
Piramal Pharma Ltd's solvency score is 62/100. The higher the solvency score, the more solvent the company is.
Score
Piramal Pharma Ltd's solvency score is 62/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
PPLPHARMA Price Targets Summary
Piramal Pharma Ltd
According to Wall Street analysts, the average 1-year price target for PPLPHARMA is 308.55 INR with a low forecast of 267.65 INR and a high forecast of 357 INR.
Dividends
Current shareholder yield for PPLPHARMA is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one PPLPHARMA stock under the Base Case scenario is 142.76 INR.
Compared to the current market price of 226.72 INR, Piramal Pharma Ltd is Overvalued by 37%.